Comments on: Cost-Utility Analysis of Fixed-Dose Combination of Indacaterol Acetate Glycopyrronium Bromide and Mometasone Furoate as a Maintenance Treatment in Adult Patients with Asthma Not Adequately Controlled with a Maintenance Combination of a Long-Acting Beta-Agonist and a High Dose of an Inhaled Corticosteroid Who Experienced One or More Asthma Exacerbations in the Previous Year.

Comments on: Cost-Utility Analysis of Fixed-Dose Combination of Indacaterol Acetate Glycopyrronium Bromide and Mometasone Furoate as a Maintenance Treatment in Adult Patients with Asthma Not Adequately Controlled with a Maintenance Combination of a Long-Acting Beta-Agonist and a High Dose of an Inhaled Corticosteroid Who Experienced One or More Asthma Exacerbations in the Previous Year. https://adreshe.com/en/cost-utility-analysis-of-fixed-dose-combination-of-indacaterol-acetate-glycopyrronium-bromide-and-mometasone-furoate-as-a-maintenance-treatment-in-adult-patients-with-asthma-not-adequately-controlled/ Health Economics & Outcomes Research Mon, 03 Mar 2025 13:49:37 +0000 hourly 1 https://wordpress.org/?v=6.9.4